Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting / De Giorgi, Vincenzo; Scarfì, Federica; Trane, Luciana; Silvestri, Flavia; Venturi, Federico; Zuccaro, Biancamaria; Spinelli, Giuseppe; Scoccianti, Silvia; De Rosa, Francesco; Dika, Emi; Longo, Caterina. - In: CANCERS. - ISSN 2072-6694. - 13:22(2021), pp. 5706-N/A. [10.3390/cancers13225706]
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
Longo, Caterina
2021
Abstract
Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.
| File | Dimensione | Formato | |
|---|---|---|---|
|
cancers-13-05706.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
269.88 kB
Formato
Adobe PDF
|
269.88 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
